恩华药业：盐酸硫必利片通过仿制药一致性评价

Core Points - Enhua Pharmaceutical (002262.SZ) announced the approval of its hydrochloride sulpiride tablets by the National Medical Products Administration, allowing the drug to pass the consistency evaluation of quality and efficacy for generic drugs [2] - The hydrochloride sulpiride tablets are indicated for conditions such as chorea, Tourette syndrome, and senile psychosis, and can also be used for ethanol intoxication [2] - The company has invested approximately 5.7 million RMB in research and development for this product [2]